• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青蒿琥酯-咯萘啶治疗在埃塞俄比亚提格雷地区阿塞德齐姆布拉区公立卫生机构就诊的无并发症恶性疟原虫疟疾患者的依从性:一项横断面研究。

Artemether-lumefantrin treatment adherence among uncomplicated plasmodium falciparum malaria patients, visiting public health facilities in AsgedeTsimbla district, Tigray, Ethiopia: a cross-sectional study.

机构信息

Tigray Regional Health Bureau, Mekelle, Tigray, Ethiopia.

College of Health Sciences, School of Public Health, Department of Epidemiology, Mekelle University, Mekelle, Tigray, Ethiopia.

出版信息

Antimicrob Resist Infect Control. 2020 Nov 10;9(1):184. doi: 10.1186/s13756-020-00846-y.

DOI:10.1186/s13756-020-00846-y
PMID:33168093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7653737/
Abstract

BACKGROUND

Ethiopia has set a goal to eliminate malaria by 2030; Artemether-lumefantrine (AL) is put as one of the cornerstone strategies for uncomplicated plasmodium falciparum malaria treatment. However, only focusing on prescribing of the treatment without assessing patients' adherence could lead to the resistance of the drug. In Ethiopia, there is limited evidence about patients' adherence to AL and its influencing factors. Therefore, this study aimed at addressing this information gap.

METHODS

A health facility based cross-sectional study was employed. Participants were selected using simple random sampling technique from registration books of the public health facilities in AsgedeTsimbla. Data were collected from March 24th to April 30th, 2018. We interviewed participants using a pre-tested structured questionnaire, and the blister pack was also inspected at their homes on day 4. Data were entered into Epi-Info and analyzed using SPSS 21. Odds ratios with 95% Confidence Intervals were estimated and the level of significance was declared at p-value ≤ 0.05.

RESULTS

A total of 384 study participants were interviewed with a response rate of 95.5%. The overall AL adherence was 53.6% (95% CI 48.4-58.3%). Children aged < 5 years [AOR: 0.4, 95% CI (0.2-0.8)], and being treated in health post [AOR: 0.3, 95% CI (0.1-0.5)] were more likely to show AL adherence whereas illiteracy [AOR: 9.4, 95% CI (4.2-21.3)], didn't know the consequence of discontinued AL [AOR: 4.0, 95% CI (2.1-7.6)], had concomitant drugs [AOR: 2.5, 95% CI (1.4-4.5)], and stopped/saved drug when improved before tablet got finished [AOR: 3.2, 95% CI (1.7-5.9)] were factors less likely to be associated with AL adherence.

CONCLUSION

AL adherence was low. Children aged < 5 years, and being treated in health post were determinants of AL adherence whereas illiteracy, didn't know the consequence of discontinued the drug, had concomitant drugs, and stopped/saved drug when improved before tablet got finished were factors that hindered the AL adherence. Stakeholders should emphasize designing appropriate strategies including educational interventions to increase the AL adherence and prevent drug resistance. Further research should be conducted to evaluate AL resistance.

摘要

背景

埃塞俄比亚设定了到 2030 年消除疟疾的目标;青蒿琥酯-咯萘啶(AL)被作为治疗无并发症恶性疟原虫疟疾的基石策略之一。然而,仅仅关注处方而不评估患者的依从性可能会导致药物产生耐药性。在埃塞俄比亚,关于患者对 AL 的依从性及其影响因素的证据有限。因此,本研究旨在填补这一信息空白。

方法

采用基于卫生机构的横断面研究。参与者采用简单随机抽样技术从公共卫生机构的登记册中选取。数据于 2018 年 3 月 24 日至 4 月 30 日收集。我们使用经过预测试的结构化问卷对参与者进行访谈,并在第 4 天在他们的家中检查泡罩包装。数据输入 Epi-Info 并使用 SPSS 21 进行分析。使用 95%置信区间的比值比进行估计,并在 p 值≤0.05 时宣布显著性水平。

结果

共对 384 名研究参与者进行了访谈,应答率为 95.5%。总体上,AL 依从性为 53.6%(95%CI 48.4-58.3%)。年龄<5 岁的儿童[AOR:0.4,95%CI(0.2-0.8)]和在卫生所接受治疗的儿童[AOR:0.3,95%CI(0.1-0.5)]更有可能表现出 AL 依从性,而文盲[AOR:9.4,95%CI(4.2-21.3)]、不知道停止 AL 治疗的后果[AOR:4.0,95%CI(2.1-7.6)]、同时服用其他药物[AOR:2.5,95%CI(1.4-4.5)]以及在药丸用完之前病情改善时停止/节省药物[AOR:3.2,95%CI(1.7-5.9)]不太可能与 AL 依从性相关。

结论

AL 依从性较低。年龄<5 岁的儿童和在卫生所接受治疗是 AL 依从性的决定因素,而文盲、不知道停止药物的后果、同时服用其他药物以及在药丸用完之前病情改善时停止/节省药物是阻碍 AL 依从性的因素。利益相关者应强调制定适当的策略,包括教育干预措施,以提高 AL 的依从性并预防耐药性。应进一步开展研究评估 AL 耐药性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b60e/7653737/10ce780c2fc4/13756_2020_846_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b60e/7653737/bd432363ee3a/13756_2020_846_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b60e/7653737/10ce780c2fc4/13756_2020_846_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b60e/7653737/bd432363ee3a/13756_2020_846_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b60e/7653737/10ce780c2fc4/13756_2020_846_Fig2_HTML.jpg

相似文献

1
Artemether-lumefantrin treatment adherence among uncomplicated plasmodium falciparum malaria patients, visiting public health facilities in AsgedeTsimbla district, Tigray, Ethiopia: a cross-sectional study.青蒿琥酯-咯萘啶治疗在埃塞俄比亚提格雷地区阿塞德齐姆布拉区公立卫生机构就诊的无并发症恶性疟原虫疟疾患者的依从性:一项横断面研究。
Antimicrob Resist Infect Control. 2020 Nov 10;9(1):184. doi: 10.1186/s13756-020-00846-y.
2
Adherence to a six-dose regimen of artemether-lumefantrine among uncomplicated Plasmodium falciparum patients in the Tigray Region, Ethiopia.在埃塞俄比亚提格雷地区,无并发症恶性疟原虫感染患者中,接受蒿甲醚-本芴醇六天疗程的治疗。
Malar J. 2011 Dec 5;10:349. doi: 10.1186/1475-2875-10-349.
3
Therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Chewaka District, Ethiopia.在埃塞俄比亚 Chewaka 区,蒿甲醚-本芴醇治疗无并发症恶性疟原虫疟疾的疗效。
Malar J. 2020 Jul 10;19(1):240. doi: 10.1186/s12936-020-03307-4.
4
Therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Arba Minch Zuria District, Gamo Zone, Southwest Ethiopia.在埃塞俄比亚西南部的 Gamo 地区的 Arba Minch Zuria 区,蒿甲醚-本芴醇治疗无并发症恶性疟原虫疟疾的疗效。
Malar J. 2024 Sep 17;23(1):282. doi: 10.1186/s12936-024-05087-7.
5
Electrocardiographic safety evaluation of extended artemether-lumefantrine treatment in patients with uncomplicated Plasmodium falciparum malaria in Bagamoyo District, Tanzania.坦桑尼亚巴加莫约区无并发症恶性疟原虫疟疾患者中延长青蒿琥酯-咯萘啶治疗的心电图安全性评估。
Malar J. 2020 Jul 14;19(1):250. doi: 10.1186/s12936-020-03309-2.
6
Parasite clearance, cure rate, post-treatment prophylaxis and safety of standard 3-day versus an extended 6-day treatment of artemether-lumefantrine and a single low-dose primaquine for uncomplicated Plasmodium falciparum malaria in Bagamoyo district, Tanzania: a randomized controlled trial.在坦桑尼亚巴加莫约地区,采用青蒿琥酯-咯萘啶标准 3 天疗程与延长 6 天疗程联合伯氨喹单剂量低剂量治疗无并发症恶性疟原虫疟疾的寄生虫清除率、治愈率、治疗后预防和安全性:一项随机对照试验。
Malar J. 2020 Jun 23;19(1):216. doi: 10.1186/s12936-020-03287-5.
7
Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial.在加蓬兰巴雷内,使用蒿甲醚-本芴醇和青蒿琥酯-阿莫地喹治疗无并发症恶性疟原虫疟疾的疗效、耐受性和安全性监测:一项开放标签临床试验。
Malar J. 2019 Dec 16;18(1):424. doi: 10.1186/s12936-019-3015-4.
8
Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial.吡喹酮-青蒿琥酯和蒿甲醚-本芴醇治疗肯尼亚儿童无并发症恶性疟原虫疟疾的随机对照非劣效试验。
Malar J. 2018 May 15;17(1):199. doi: 10.1186/s12936-018-2340-3.
9
Therapeutic Efficacy of Artemether-Lumefantrine (Coartem®) in Treating Uncomplicated P. falciparum Malaria in Metehara, Eastern Ethiopia: Regulatory Clinical Study.蒿甲醚-本芴醇(科泰复®)治疗埃塞俄比亚东部梅特哈拉无并发症恶性疟原虫疟疾的疗效:注册临床研究
PLoS One. 2016 Apr 29;11(4):e0154618. doi: 10.1371/journal.pone.0154618. eCollection 2016.
10
Prescriber practices and patient adherence to artemisinin-based combination therapy for the treatment of uncomplicated malaria in Guinea, 2016.2016 年,在几内亚,医生的用药习惯和患者对青蒿素类复方疗法治疗无并发症疟疾的用药依从性。
Malar J. 2019 Jan 25;18(1):23. doi: 10.1186/s12936-019-2664-7.

引用本文的文献

1
Impact of health education intervention on the patients' adherence to malaria artemisinin-based combination therapy in Kamuli District, Uganda.健康教育干预对乌干达卡穆利区患者坚持以青蒿素为基础的疟疾联合治疗的影响。
Malar J. 2025 Jun 12;24(1):189. doi: 10.1186/s12936-025-05444-0.
2
Perceived causes and solutions for malaria prevalence among seasonal migrant workers in Northwest Ethiopia: a qualitative study.埃塞俄比亚西北部季节性流动工人中疟疾流行的感知原因及解决办法:一项定性研究
Malar J. 2025 Feb 17;24(1):47. doi: 10.1186/s12936-024-05231-3.
3
Factors influencing patients' adherence to malaria artemisinin-based combination therapy in Kamuli District, Uganda.

本文引用的文献

1
Patients' adherence to artemisinin-based combination therapy and healthcare workers' perception and practice in Savannakhet province, Lao PDR.老挝人民民主共和国沙湾拿吉省患者对基于青蒿素的联合疗法的依从性以及医护人员的认知与实践
Trop Med Health. 2018 Dec 22;46:44. doi: 10.1186/s41182-018-0125-6. eCollection 2018.
2
Therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Ethiopia: a systematic review and meta-analysis.蒿甲醚-本芴醇治疗埃塞俄比亚无并发症恶性疟原虫疟疾的疗效:系统评价和荟萃分析。
Infect Dis Poverty. 2017 Nov 15;6(1):157. doi: 10.1186/s40249-017-0372-5.
3
乌干达卡穆利地区影响疟疾青蒿素类复方疗法用药依从性的因素。
Malar J. 2024 Jan 2;23(1):1. doi: 10.1186/s12936-023-04824-8.
4
Adherence to Anti-Malarial Treatment in Malaria Endemic Areas of Bangladesh.孟加拉国疟疾流行地区对抗疟治疗的依从性
Pathogens. 2023 Nov 27;12(12):1392. doi: 10.3390/pathogens12121392.
5
Determinants of Patients' Adherence to Malaria Treatment in the Democratic Republic of the Congo.刚果民主共和国患者对疟疾治疗依从性的决定因素
Trop Med Infect Dis. 2022 Jul 18;7(7):138. doi: 10.3390/tropicalmed7070138.
6
Current Epidemiological Characteristics of Imported Malaria, Vector Control Status and Malaria Elimination Prospects in the Gulf Cooperation Council (GCC) Countries.海湾合作委员会(GCC)国家输入性疟疾的当前流行病学特征、病媒控制状况及疟疾消除前景
Microorganisms. 2021 Jul 2;9(7):1431. doi: 10.3390/microorganisms9071431.
7
Current Status and the Epidemiology of Malaria in the Middle East Region and Beyond.中东地区及其他地区疟疾的现状与流行病学
Microorganisms. 2021 Feb 9;9(2):338. doi: 10.3390/microorganisms9020338.
Medication Adherence Measures: An Overview.
药物依从性测量:概述
Biomed Res Int. 2015;2015:217047. doi: 10.1155/2015/217047. Epub 2015 Oct 11.
4
Adherence to Artemisinin Combination Therapy for the treatment of uncomplicated malaria in the Democratic Republic of the Congo.在刚果民主共和国坚持使用青蒿素联合疗法治疗非复杂性疟疾。
F1000Res. 2015 Feb 24;4:51. doi: 10.12688/f1000research.6122.2. eCollection 2015.
5
Are Tanzanian patients attending public facilities or private retailers more likely to adhere to artemisinin-based combination therapy?坦桑尼亚前往公共医疗机构或私人零售商处就诊的患者,哪类更有可能坚持使用青蒿素联合疗法?
Malar J. 2015 Feb 19;14:87. doi: 10.1186/s12936-015-0602-x.
6
Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting.在肯尼亚加里萨县冲突环境下接受三年医疗保健后患者对规定的青蒿素联合疗法的依从性。
Malar J. 2015 Mar 24;14:125. doi: 10.1186/s12936-015-0645-z.
7
Patient related factors affecting adherence to antimalarial medication in an urban estate in ghana.影响加纳一个城市社区抗疟药物依从性的患者相关因素。
Malar Res Treat. 2015;2015:452539. doi: 10.1155/2015/452539. Epub 2015 Feb 12.
8
Adherence to artemether-lumefantrine drug combination: a rural community experience six years after change of malaria treatment policy in Tanzania.对蒿甲醚-本芴醇联合用药的依从性:坦桑尼亚疟疾治疗政策变更六年后的农村社区经验
Malar J. 2014 Jul 10;13:267. doi: 10.1186/1475-2875-13-267.
9
Cluster randomized trial of text message reminders to retail staff in tanzanian drug shops dispensing artemether-lumefantrine: effect on dispenser knowledge and patient adherence.坦桑尼亚药店分发青蒿琥酯-苯芴醇时,用短信提醒零售店员的整群随机对照试验:对配药者知识和患者依从性的影响。
Am J Trop Med Hyg. 2014 Oct;91(4):844-853. doi: 10.4269/ajtmh.14-0126. Epub 2014 Jul 7.
10
How patients take malaria treatment: a systematic review of the literature on adherence to antimalarial drugs.患者如何接受疟疾治疗:关于抗疟药物依从性的文献系统综述
PLoS One. 2014 Jan 20;9(1):e84555. doi: 10.1371/journal.pone.0084555. eCollection 2014.